China Health Group Limited (HKG:0673)
Hong Kong · Delayed Price · Currency is HKD 0.2950
+0.0050 (1.72%)
Aug 21, 2026, 3:25 PM HKT
China Health Group Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 41.09 | 38.94 | 59.93 | 76.41 | 107.03 | |
Revenue Growth | 5.52% | -35.02% | -21.57% | -28.60% | 21.77% |
Cost of Revenue | 33.96 | 29.71 | 46.29 | 49.22 | 78.34 |
Gross Profit | 7.13 | 9.24 | 13.64 | 27.19 | 28.69 |
Selling, General & Admin | 41.31 | 68.83 | 50.23 | 39.99 | 39.22 |
Other Operating Expenses | -0.39 | -16.54 | -37.7 | - | - |
Operating Expenses | 41.14 | 52.3 | 13.26 | 40.02 | 39.99 |
Operating Income | -34.01 | -43.06 | 0.38 | -12.82 | -11.3 |
Interest Expense | -0.19 | -0.25 | -0.33 | -2.19 | -0.29 |
Interest & Investment Income | 0 | 0.01 | 0.92 | 0.44 | 0.33 |
Earnings From Equity Investments | - | - | - | -4 | - |
Other Non Operating Income (Expenses) | -0.41 | -5.95 | 0.03 | -3.35 | -1.9 |
EBT Excluding Unusual Items | -34.6 | -49.25 | 1 | -21.92 | -13.16 |
Merger & Restructuring Charges | - | - | -1.33 | - | -0.3 |
Impairment of Goodwill | -4.4 | -11.75 | -13.83 | - | - |
Gain (Loss) on Sale of Assets | -2.42 | - | 3.31 | -0.23 | - |
Other Unusual Items | -7.44 | -6.38 | -31.44 | -17.23 | 4.75 |
Pretax Income | -48.85 | -67.38 | -42.29 | -39.38 | -8.71 |
Income Tax Expense | -0.43 | 0.44 | 0.2 | 0.18 | 0.41 |
Earnings From Continuing Operations | -48.43 | -67.82 | -42.5 | -39.56 | -9.11 |
Minority Interest in Earnings | 0.49 | 0.03 | 2.31 | -2.49 | -3.09 |
Net Income | -47.93 | -67.79 | -40.19 | -42.05 | -12.21 |
Net Income to Common | -47.93 | -67.79 | -40.19 | -42.05 | -12.21 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 967 | 603 | 475 | 427 | 412 |
Shares Outstanding (Diluted) | 967 | 603 | 475 | 427 | 412 |
Shares Change | 60.43% | 26.77% | 11.46% | 3.48% | - |
EPS (Basic) | -0.05 | -0.11 | -0.08 | -0.10 | -0.03 |
EPS (Diluted) | -0.05 | -0.11 | -0.08 | -0.10 | -0.03 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -86.14 | -8.35 | -7.03 | -20.98 | 31.15 |
Free Cash Flow Per Share | -0.09 | -0.01 | -0.01 | -0.05 | 0.08 |
Gross Margin | 17.35% | 23.71% | 22.76% | 35.59% | 26.81% |
Operating Margin | -82.76% | -110.58% | 0.63% | -16.78% | -10.56% |
Profit Margin | -116.65% | -174.07% | -67.06% | -55.02% | -11.40% |
Free Cash Flow Margin | -209.62% | -21.45% | -11.72% | -27.46% | 29.10% |
EBITDA | -32.21 | -40.67 | 3.25 | -10.11 | -8.38 |
EBITDA Margin | -78.38% | -104.43% | 5.42% | -13.23% | -7.83% |
D&A For EBITDA | 1.8 | 2.4 | 2.87 | 2.72 | 2.92 |
EBIT | -34.01 | -43.06 | 0.38 | -12.82 | -11.3 |
EBIT Margin | -82.76% | -110.58% | 0.63% | -16.78% | -10.56% |